Decentralized clinical trials and real-world data (RWD) are two of the most commonly cited approaches for driving greater efficiency and patient-centricity in clinical research, but can they be brought together to drive even greater impact? This panel discussion, hosted by THREAD, will explore specific strategies for applying RWD to decentralized clinical trials to make research easier to participate in and to produce more comprehensive evidence on the clinical trial population.
Use cases for discussion include:
- Strategies for using RWD to enhance decentralized clinical trial recruitment
- Opportunities for maximizing the impact of source data by combining site-generated source data and participant/caregiver source data to minimize monitoring burden
- Ensuring a comprehensive understanding of a trial participant’s course of care – before, during, and after the primary trial observation period
- Combining integrated EHR networks with decentralized clinical trial technology for registries
Join this webinar to learn how RWD can be used to make decentralized clinical trials more efficient and to add evidence to the core clinical data set.
Joss Warren, Executive Director, Head of Strategy & Partnerships, THREAD Research
Joss is Executive Director and Head of Strategy & Partnerships at THREAD Research, a leading provider of Decentralized Clinical Trial technologies for life sciences. In his role, Joss oversees THREAD’s corporate strategy and establishes strategic relationships with third parties to develop collaborative solutions that integrate with THREAD’s decentralized clinical trial (DCT) platform. These partnerships help drive THREAD’s mission of creating a single comprehensive experience for decentralized research to make studies more inclusive and more efficient.Message Presenter
Jason LaBonte, CSO, Datavant
Jason has 20 years of experience in health information, market research, and commercial benchmarking, and has held prior executive leadership roles at Decision Resources Group, MedPanel, and Universal Patient Key. Jason has designed and launched successful new products at every stage of his career. Jason has an AB in Molecular Biology from Princeton and a PhD in Virology from Harvard.Message Presenter
Hugh Levaux, CEO, Protocol First
Dr. Hugh Levaux is Founder and CEO of Protocol First. The company offers innovative software solutions for clinical research at the confluence of remote monitoring and data science. Key products are: Protocol First’s eProtocol, Source Upload and EDC integrated platform or Clinical Pipe — industry’s first system-agnostic EHR-to-EDC connector application.
Dr. Levaux brings to Protocol First 20 years of dedicated experience in clinical trial design and operations, as well as web-based technologies—notably, SVP at United BioSource Corporation (UBC), VP of Product Strategy at Medidata Solutions; CEO of Ninaza, a web-based EDC provider; and SVP at Quintiles (IQVIA now). Dr. Levaux has developed and commercialized multiple eClinical technologies in EDC, IVR/RTSM, ePRO/eCOA and trial-related technologies.
Dr. Levaux holds a Ph.D. in Policy Analysis from the RAND Graduate School.Message Presenter
Brigham Hyde, President, Eversana
Brigham is President of Data & Analytics at EVERSANA a complete commercialization partner for Pharma. Prior to EVERSANA, he served as a founding member of Symphony AI, a $1B VC/PE firm, where he led the investment and was an operating founder of Concerto Health AI an RWD an AI Platform technology company focused on improving outcomes in Oncology. Previously, he served as CDO for Decision Resources Group, who acquired his first venture Relay Technology Management. Dr. Hyde holds adjunct positions at Tufts University and M.I.T. Media Lab and is a regular lecturer on Real-World Data and AI in Healthcare.Message Presenter
Who Should Attend?
Anyone interested in learning more about tangible strategies for effectively using RWD in a decentralized clinical trial context is encouraged to join.
What You Will Learn
RWD has certain high value applications specific to decentralized clinical trials. Join this webinar to learn how RWD can be used to make decentralized clinical trials more efficient and to add evidence to the core clinical data set.
THREAD is a leading provider of a proprietary, decentralized research platform and suite of supporting services used by biopharma, CROs and life science organizations to remotely capture data from participants and sites during, in-between and in lieu of in-clinic visits. THREAD’s platform and supporting services are helping customers to shorten study launch timelines, reduce study budgets with Virtual Visits, and bring studies from the clinic to patients’ homes. THREAD provides key platform features such as eConsent, eCOA/ePRO, sensors, reminders, and telehealth Virtual Visits to support remote data capture, hybrid virtual studies, and fully decentralized studies in key therapeutic areas. In 2019, THREAD was acquired by strategic health care investors Water Street Healthcare Partners and JLL Partners. Visit us at https://www.threadresearch.com/